ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
7.97
-0.01 (-0.13%)
At close: Jun 5, 2026, 4:00 PM EDT
8.00
+0.03 (0.39%)
After-hours: Jun 5, 2026, 7:27 PM EDT
ADMA Biologics Employees
As of December 31, 2025, ADMA Biologics had 647 total employees, including 640 full-time and 7 part-time employees. The number of employees decreased by 38 or -5.55% compared to the previous year.
Employees
647
Change (1Y)
-38
Growth (1Y)
-5.55%
Revenue / Employee
$788,043
Profits / Employee
$255,570
Market Cap
1.85B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 647 | -38 | -5.55% | 640 | 7 |
| Dec 31, 2024 | 685 | 61 | 9.78% | 677 | 8 |
| Dec 31, 2023 | 624 | 7 | 1.13% | 624 | 0 |
| Dec 31, 2022 | 617 | 90 | 17.08% | 617 | 0 |
| Dec 31, 2021 | 527 | 120 | 29.48% | 527 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Lakefront Biotherapeutics NV | 558 |
| Vericel | 398 |
| Nuvation Bio | 307 |
| Harmony Biosciences Holdings | 293 |
| Viridian Therapeutics | 252 |
| Zymeworks | 243 |
| Stoke Therapeutics | 170 |
| Nanobiotix | 100 |
ADMA News
- 2 days ago - ADMA Legal Claims: ADMA Biologics may have Misrepresented its Revenue Sources to Investors – Contact BFA Law about its Pending Securities Fraud Investigation - GlobeNewsWire
- 3 days ago - ADMA Biologics Transcript: AGM 2026 - Transcripts
- 7 days ago - $ADMA Securities News: ADMA Biologics Investigated for Securities Fraud Over Channel Stuffing Allegations – Investors with Losses Notified to Contact BFA Law - GlobeNewsWire
- 11 days ago - $ADMA Shareholder Announcement: ADMA Biologics may have Misled Investors about its Revenue – Contact BFA Law about its Pending Investigation - GlobeNewsWire
- 14 days ago - ADMA Inquiry News: ADMA Biologics Investors are Notified of BFA Law's Ongoing Investigation into the Company's Potential Misstatements – Contact the Firm if You Lost Money - GlobeNewsWire
- 16 days ago - ADMA Securities Investigation: ADMA Biologics 29% Stock Drop Triggers Securities Fraud Investigation Over Channel Stuffing Claims – Investors Urged to Contact BFA Law - GlobeNewsWire
- 18 days ago - ADMA Fraud Notice: ADMA Biologics is being Investigated for Securities Fraud after 29% Stock Drop -- Investors Reminded to Contact BFA Law - GlobeNewsWire
- 21 days ago - ADMA Shareholder News: ADMA Biologics Investigated for Securities Fraud Over Alleged Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law - GlobeNewsWire